• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类围产期心肌病与扩张型心肌病的转录组学比较揭示关键疾病通路的差异。

Transcriptomic Comparison of Human Peripartum and Dilated Cardiomyopathy Identifies Differences in Key Disease Pathways.

作者信息

Taylor Jude, Yeung Anna C Y, Ashton Anthony, Faiz Alen, Guryev Victor, Fang Bernard, Lal Sean, Grosser Mark, Dos Remedios Cristobal G, Braet Filip, McLachlan Craig S, Li Amy

机构信息

Centre for Healthy Futures, Torrens University Australia, Surrey Hills, NSW 2010, Australia.

Respiratory Bioinformatics and Molecular Biology, School of Life Sciences, The University of Technology Sydney (UTS), Sydney, NSW 2007, Australia.

出版信息

J Cardiovasc Dev Dis. 2023 Apr 23;10(5):188. doi: 10.3390/jcdd10050188.

DOI:10.3390/jcdd10050188
PMID:37233155
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10218903/
Abstract

Peripartum cardiomyopathy (PPCM) is a rare form of acute onset heart failure that presents in otherwise healthy pregnant women around the time of delivery. While most of these women respond to early intervention, about 20% progress to end-stage heart failure that symptomatically resembles dilated cardiomyopathy (DCM). In this study, we examined two independent RNAseq datasets from the left ventricle of end-stage PPCM patients and compared gene expression profiles to female DCM and non-failing donors. Differential gene expression, enrichment analysis and cellular deconvolution were performed to identify key processes in disease pathology. PPCM and DCM display similar enrichment in metabolic pathways and extracellular matrix remodeling suggesting these are similar processes across end-stage systolic heart failure. Genes involved in golgi vesicles biogenesis and budding were enriched in PPCM left ventricles compared to healthy donors but were not found in DCM. Furthermore, changes in immune cell populations are evident in PPCM but to a lesser extent compared to DCM, where the latter is associated with pronounced pro-inflammatory and cytotoxic T cell activity. This study reveals several pathways that are common to end-stage heart failure but also identifies potential targets of disease that may be unique to PPCM and DCM.

摘要

围产期心肌病(PPCM)是一种罕见的急性发作性心力衰竭形式,发生在分娩前后原本健康的孕妇身上。虽然这些女性中的大多数对早期干预有反应,但约20%会进展为终末期心力衰竭,其症状类似于扩张型心肌病(DCM)。在本研究中,我们检查了来自终末期PPCM患者左心室的两个独立RNA测序数据集,并将基因表达谱与女性DCM患者和未患心力衰竭的供体进行了比较。进行了差异基因表达、富集分析和细胞反卷积,以确定疾病病理中的关键过程。PPCM和DCM在代谢途径和细胞外基质重塑方面表现出相似的富集,表明这些是终末期收缩性心力衰竭的相似过程。与健康供体相比,参与高尔基体囊泡生物发生和出芽的基因在PPCM左心室中富集,但在DCM中未发现。此外,免疫细胞群体的变化在PPCM中很明显,但与DCM相比程度较小,后者与明显的促炎和细胞毒性T细胞活性相关。这项研究揭示了终末期心力衰竭的几种常见途径,但也确定了可能是PPCM和DCM特有的疾病潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/7a44e165ac5f/jcdd-10-00188-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/ee07b62a99e2/jcdd-10-00188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/49ebd105fbe8/jcdd-10-00188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/742711ba4099/jcdd-10-00188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/bf642c227cb4/jcdd-10-00188-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/9d1ade70e57f/jcdd-10-00188-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/7a44e165ac5f/jcdd-10-00188-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/ee07b62a99e2/jcdd-10-00188-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/49ebd105fbe8/jcdd-10-00188-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/742711ba4099/jcdd-10-00188-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/bf642c227cb4/jcdd-10-00188-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/9d1ade70e57f/jcdd-10-00188-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebcb/10218903/7a44e165ac5f/jcdd-10-00188-g006.jpg

相似文献

1
Transcriptomic Comparison of Human Peripartum and Dilated Cardiomyopathy Identifies Differences in Key Disease Pathways.人类围产期心肌病与扩张型心肌病的转录组学比较揭示关键疾病通路的差异。
J Cardiovasc Dev Dis. 2023 Apr 23;10(5):188. doi: 10.3390/jcdd10050188.
2
Cardiovascular Magnetic Resonance in Peripartum Cardiomyopathy: Comparison with Idiopathic Dilated Cardiomyopathy.围产期心肌病的心血管磁共振成像:与特发性扩张型心肌病的比较
Diagnostics (Basel). 2021 Sep 24;11(10):1752. doi: 10.3390/diagnostics11101752.
3
Comparison of clinical outcomes in peripartum cardiomyopathy and age-matched dilated cardiomyopathy: A 15-year nationwide population-based study in Asia.围产期心肌病与年龄匹配的扩张型心肌病临床结局比较:一项基于亚洲全国人口的15年研究
Medicine (Baltimore). 2017 May;96(19):e6898. doi: 10.1097/MD.0000000000006898.
4
Myofilament Remodeling and Function Is More Impaired in Peripartum Cardiomyopathy Compared with Dilated Cardiomyopathy and Ischemic Heart Disease.与扩张型心肌病和缺血性心脏病相比,围产期心肌病的肌丝重塑和功能受损更严重。
Am J Pathol. 2017 Dec;187(12):2645-2658. doi: 10.1016/j.ajpath.2017.08.022. Epub 2017 Sep 19.
5
Increased Cancer Prevalence in Peripartum Cardiomyopathy.围产期心肌病患者癌症患病率增加。
JACC CardioOncol. 2019 Dec 17;1(2):196-205. doi: 10.1016/j.jaccao.2019.09.008. eCollection 2019 Dec.
6
Peripartum cardiomyopathy and familial dilated Cardiomyopathy: a tale of two cases.围产期心肌病与家族性扩张型心肌病:两例病例报告
Cardiovasc J Afr. 2013 Jun 23;24(5):e4-7. doi: 10.5830/CVJA-2013-027.
7
Unveiling the Mystery of Peripartum Cardiomyopathy: A Traditional Review.揭开围产期心肌病之谜:传统综述
Cureus. 2020 Oct 4;12(10):e10790. doi: 10.7759/cureus.10790.
8
Peripartum cardiomyopathy and dilated cardiomyopathy: different at heart.围产期心肌病与扩张型心肌病:本质不同。
Front Physiol. 2015 Jan 15;5:531. doi: 10.3389/fphys.2014.00531. eCollection 2014.
9
Cardiomyopathy discovered during pregnancy: Insights from speckle tracking echocardiography in a cohort of pregnant patients.孕期发现的心肌病:来自一组孕妇斑点追踪超声心动图的见解
ARYA Atheroscler. 2024 Mar-Apr;20(2):8-16. doi: 10.48305/arya.2024.42400.2932.
10
Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy.肌联蛋白基因突变常见于围生期心肌病和扩张型心肌病的家族中。
Eur Heart J. 2014 Aug 21;35(32):2165-73. doi: 10.1093/eurheartj/ehu050. Epub 2014 Feb 20.

引用本文的文献

1
CD4 T Cell Subsets and as Novel Biomarkers of Immune Dysregulation in Dilated Cardiomyopathy.CD4 T细胞亚群作为扩张型心肌病免疫失调的新型生物标志物
Int J Mol Sci. 2025 Aug 13;26(16):7806. doi: 10.3390/ijms26167806.
2
Aims and Rationale of a National Registry Integrating Clinical, Echocardiographic, and Multi-Omics Profiling to Promote Precision Medicine in Peripartum Cardiomyopathy.整合临床、超声心动图和多组学分析以促进围产期心肌病精准医学的国家登记处的目标和基本原理
Biomedicines. 2025 Aug 20;13(8):2026. doi: 10.3390/biomedicines13082026.
3
Transcriptional meta-analysis and immune cell profiles reveal altered neutrophil dynamics in chronic atrial fibrillation.

本文引用的文献

1
Single-cell transcriptomics reveals cell-type-specific diversification in human heart failure.单细胞转录组学揭示了人类心力衰竭中细胞类型特异性的多样化。
Nat Cardiovasc Res. 2022 Mar;1(3):263-280. doi: 10.1038/s44161-022-00028-6. Epub 2022 Mar 16.
2
Exploration of dilated cardiomyopathy for biomarkers and immune microenvironment: evidence from RNA-seq.扩张型心肌病生物标志物和免疫微环境研究:来自 RNA-seq 的证据。
BMC Cardiovasc Disord. 2022 Jul 18;22(1):320. doi: 10.1186/s12872-022-02759-7.
3
Peripartum cardiomyopathy: a global effort to find the cause and cure for the rare and little understood disease.
转录元分析和免疫细胞图谱揭示慢性心房颤动中中性粒细胞动力学的改变。
R Soc Open Sci. 2025 Mar 5;12(3):241102. doi: 10.1098/rsos.241102. eCollection 2025 Mar.
4
The molecular and cellular landscape of hypertrophic cardiomyopathy phenotypes: transition from obstructive to end-stage heart failure.肥厚型心肌病表型的分子和细胞格局:从梗阻性到终末期心力衰竭的转变。
J Mol Med (Berl). 2025 Jan;103(1):113-123. doi: 10.1007/s00109-024-02508-7. Epub 2025 Jan 7.
5
Myocardial Posttranscriptional Landscape in Peripartum Cardiomyopathy.围产期心肌病的心肌转录后图谱
Circ Heart Fail. 2024 Dec;17(12):e011725. doi: 10.1161/CIRCHEARTFAILURE.124.011725. Epub 2024 Nov 8.
6
Pharmacological interventions for peripartum cardiomyopathy.围生期心肌病的药物干预。
Cochrane Database Syst Rev. 2024 Oct 30;10(10):CD014851. doi: 10.1002/14651858.CD014851.
围产期心肌病:一项寻找这种罕见且了解甚少的疾病病因及治疗方法的全球行动。
Biophys Rev. 2022 Jan 24;14(1):369-379. doi: 10.1007/s12551-022-00930-0. eCollection 2022 Feb.
4
Proinflammatory TH17 cytokine activation, disease severity and outcomes in peripartum cardiomyopathy.围生期心肌病中促炎 TH17 细胞因子的激活、疾病严重程度和结局。
Int J Cardiol. 2021 Sep 15;339:93-98. doi: 10.1016/j.ijcard.2021.06.022. Epub 2021 Jul 3.
5
Immune Cells and Immunotherapy for Cardiac Injury and Repair.免疫细胞与免疫疗法在心脏损伤与修复中的作用。
Circ Res. 2021 May 28;128(11):1766-1779. doi: 10.1161/CIRCRESAHA.121.318005. Epub 2021 May 27.
6
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy.围生期心肌病的遗传与表型特征。
Circulation. 2021 May 11;143(19):1852-1862. doi: 10.1161/CIRCULATIONAHA.120.052395. Epub 2021 Apr 20.
7
Single Nuclei Sequencing Reveals Novel Insights Into the Regulation of Cellular Signatures in Children With Dilated Cardiomyopathy.单核测序揭示了对扩张型心肌病患儿细胞特征调控的新见解。
Circulation. 2021 Apr 27;143(17):1704-1719. doi: 10.1161/CIRCULATIONAHA.120.051391. Epub 2021 Feb 23.
8
Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism.患有心肌病的围产期患者的人诱导多能干细胞衍生心肌细胞揭示了脂质代谢的异常调节。
Circulation. 2020 Dec 8;142(23):2288-2291. doi: 10.1161/CIRCULATIONAHA.119.044962. Epub 2020 Dec 7.
9
Distinct Myocardial Transcriptomic Profiles of Cardiomyopathies Stratified by the Mutant Genes.不同基因突变导致的心肌病的心肌转录组特征明显不同。
Genes (Basel). 2020 Nov 28;11(12):1430. doi: 10.3390/genes11121430.
10
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.围生期心肌病患者的临床表现、处理和 6 个月结局:ESC-EORP 注册研究。
Eur Heart J. 2020 Oct 14;41(39):3787-3797. doi: 10.1093/eurheartj/ehaa455.